All 42 planned patients in Xvivo Perfusion’s American clinical trial using STEEN Solution™ have received transplants. In the ongoing follow-up good clinical results have been obtained. The patients are being followed up over a period of one year. During a meeting with the FDA it was decided that the expert panel meeting preceding the decision on HDE registration (Humanitarian Device Exemption) will be held within four to five months. During the meeting the FDA’s remaining questions were also discussed. Following the advice of the FDA, the clinics taking part in the trial are continuing to transplant lungs that have been perfused outside the body using STEEN Solution™ and so far 52 patients have received transplants at the centers taking part in the trial. The NOVEL trial is being performed at 7 centers in the USA and was designed to safely increase the number of usable lungs from the donor pool. In the study, clinical outcomes associated with ex-vivo lung perfusion (EVLP) of organs initially assessed to be unusable were compared with a control group consisting of lungs that were transplanted after having been initially assessed to be usable. A total of 42 patients received transplants using the STEEN Solution™ method and these were matched with 42 control patients. The results so far from the study continue to indicate that lungs evaluated using STEEN Solution™ perform as well as lungs transplanted directly. "It is a big step forward for XVIVO Perfusion that the FDA has now decided to hold an expert panel meeting. Such meetings precede decisions on registration. Unfortunately the FDA is not able to hold this meeting until after the turn of the year. We continue to note that clinics in the USA continue to show great interest in STEEN Solution™," says Dr Magnus Nilsson, CEO at XVIVO Perfusion. September 20, 2013 Gothenburg XVIVO Perfusion AB (publ) Magnus Nilsson CEO For further information please contact: Christoffer Rosenblad, CFO, tel: 46 31 788 21 59, e-mail: christoffer.rosenblad@xvivoperfusion.com For further information on XVIVO Perfusion’s business, please refer to the company’s website, www.xvivoperfusion.com Xvivo Perfusion is required to publish the information in this press release in accordance with the Swedish Securities Market Act and/or the Financial Instruments Trading Act. The information was submitted for publication on September 20, 2013 at 4:55 p.m. This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails. ________________________________________________________________________________ _ _____________________________________ XVIVO Perfusion AB is a medical technology company which develops solutions and systems for assessing and preserving organs outside the body and for selecting usable organs and maintaining them in optimal condition pending transplantation. The company is headquartered in Gothenburg, Sweden, and has one office in the USA. The Xvivo share is listed on NASDAQ OMX First North and has the ticker symbol XVIVO. More information can be found on the website www.xvivoperfusion.com. The Certified Adviser is Redeye, www.redeye.se. ________________________________________________________________________________ _ _____________________________________ XVIVO Perfusion AB (publ), Box 53015, SE-400 14 Göteborg. Corporate identity number 556561-0424. Tel: 46 31 788 21 50. Fax: 46 31 788 21 69. E-mail: info@xvivoperfusion.com. Website: www.xvivoperfusion.com
NOVEL trial recruitment of patients complete, FDA has
Top 10 Most Recent News Articles
Jiangxi Dialogues: Youths Forge Global Ties in 2026
Bringing Global Youth to the Table In the heart of Jiangxi, China, young minds from across the globe gathered not just to chat but to shape the future. A bunch who only a decade ago might have been ignored in such circles are now leading discussions, and they’ve kicked off their powwow on September 22, 2026, with a bang in Nanchang. What’s the Agenda? Imagine more...
Continue Reading
Buying Land in Greeneville: Avoiding Costly Mistakes
Diving Headfirst into Raw Land Purchases Buying land isn't like your typical house flip in Greeneville, Tennessee. It's a whole different ballgame out there. You might think you're just purchasing a piece of Mother Earth, but you got to know there's more beneath the surface—quite literally—before you sign anything. You can go from a promising adventure to a...
Continue Reading
Kailas Campaign Binds Climbers with Gear, Trust
Embracing the Spirit of Climbing Connections Alright, so when's the last time you saw a brand digging into the human side of one rugged sport like climbing? That's where Kailas steps in, pulling us beyond gear talk into the trust and camaraderie that defines climbing. Their latest effort—dubbed “Stay Warm, Stay Together”—goes beyond mere technical prowess by...
Continue Reading
RingConn Smart Ring Gains Key FDA 510(k) Clearance
FDA Clearance: A Major Step for RingConn In a space where every tiny gadget-maker is desperately clawing for a regulatory nod, RingConn—a venture born from Shenzhen Ninenovo Technology Limited—has snagged an FDA 510(k) clearance (Clearance No. K260490) for their wearable Smart Ring that measures blood oxygen levels non-invasively. October 10, 2026, marked the day when...
Continue Reading
AI in Music: CITY JAM Focuses on Human Creativity
Breaking Down the AI Music Race In the wild world of music production, AI's making waves. Here's the thing though—it's all about how fast and how much it can churn out. Now, won't lie to you, that's impressive, but not the full picture. Pat Villaceran, the brain behind CITY JAM, is adamant that the real gold isn't just speed. It's the unique sound each artist brings to...
Continue Reading
ONLYOFFICE 10.0 Boosts AI and Security Features
A Fresh Look at ONLYOFFICE 10.0's Game-Changing Update Outta the gates swinging, ONLYOFFICE dropped their latest 10.0 update. This one ain't just your average software facelift—it's packing some serious heat with AI enhancements, brand spanking new modular apps, and beefed-up security features that'll make anyone dealing with sensitive data breathe a little easier. AI...
Continue Reading
CenterPoint Deploys Crews for Hurricane Aid Relief
CenterPoint’s Commitment Amidst Crisis Now, when a hurricane slams into the coast, it’s go time for everyone in the game. CenterPoint Energy, never one to sit on the sidelines, is showing up with a hefty squad to help fix the mess left by Hurricane Isaias. A robust 355-strong team is heading out to assist with power restoration down there in Florida. This isn’t just...
Continue Reading
Emdoor’s Rugged Devices Fuel Industry Growth Globally
Emdoor Information: A Sturdy Path in Rugged Computing Dive into the heart of the rugged computing terrain, and you may very well run into Emdoor Information—an 18-year-old titan from Shenzhen that’s carved its niche on the backs of rugged tablets, laptops, and handhelds. Publicly listed since 2023 on China’s A-share main board, Emdoor isn't just any player in this...
Continue Reading
tm:rw Revolutionizes Retail with Live TikTok Studios
tm:rw Takes a Bold Step into Social Commerce Throw out whatever you've thought about traditional brick-and-mortar retail because tm:rw isn't just bending the rules—it's burning the book. Launching nine branded studio spaces at their Times Square flagship, tm:rw is blending live streaming with in-person shopping, all in sync with TikTok Shop. The experience is less about...
Continue Reading
Haag-Streit Debuts Innovative Octopus 910 Perimeter at AAO
Now here's something that'll tickle your ophthalmologist's fancy—Haag-Streit USA has rolled out the Octopus 910, a slick piece of kit set to shake up visual field testing for glaucoma management. This time, they're getting in front of the competition, unveiling it at the Association for Research in Vision and Ophthalmology's 2026 shindig in New Orleans. With this new...
Continue ReadingTop 5 Most Recently Viewed Articles
JPMorgan Global Growth & Income Expands Share Issuance
JPMorgan Global Growth & Income Expands Share Issuance JPMorgan Global Growth & Income PLC has announced an exciting development as they proceed with the issuance of 100,000 new Ordinary Shares. This strategic move, priced at 583.00 pence per share, is part of their ongoing efforts to enhance shareholder value and boost liquidity. Current Share Structure With this latest...
Continue Reading
Key Insights into Ricardo Plc's Trading Activities
Understanding the Form 8.5 for Ricardo Plc The Form 8.5 (EPT/RI) provides essential details about trading activities for Ricardo Plc, which is crucial for investors and analysts following the company's market actions. This document underscores the importance of transparency and compliance with regulatory frameworks governing trading disclosures. Key Trader Information One...
Continue Reading
Enhancing Nurse Safety and Well-Being Through Legislation
Enhancing Nurse Safety and Well-Being Through Legislation Emergency nurses nationwide are voicing a crucial message to lawmakers about two primary concerns: workplace safety and the overall well-being of healthcare workers. As they gather in the nation's capital, these dedicated professionals highlight the significance of new legislation aimed at improving their working...
Continue Reading
Unlocking Mexico's Stock Market Potential Amid Challenges
Mexico's Stock Market: A Hidden Gem for Investors Despite facing numerous political and economic hurdles, Mexico's equity market offers an intriguing opportunity for those looking to invest for the long haul. Analysts argue that the market is significantly undervalued when compared to global peers and historical performance metrics. Current Economic Climate and Its Impact...
Continue Reading
Brightspeed Unveils Exciting Offer for New Fiber Internet Users
Brightspeed Introduces New Fiber Internet Offers Brightspeed, recognized as the third-largest fiber broadband builder in the nation, is eager to enhance connectivity for homes and businesses by offering enticing new pricing options. Their latest promotion focuses on encouraging new subscribers as well as existing customers looking to upgrade to fiber service. Exciting...
Continue Reading